Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 11, 2026
MicroAlgo (MLGO) Eyes $8 Target: Analyzing the Potential +96% Upside

MicroAlgo (MLGO) Eyes $8 Target: Analyzing the Potential +96% Upside

Key Takeaways

  • MicroAlgo Inc. (MLGO) currently trades near $4.08, making the $8 target a potential upside of roughly 96% from current levels.
  • The company returned to profitability in fiscal 2025, posting net income of approximately $16.3 million, a 195% year-over-year improvement, alongside an exceptionally low price-to-earnings (P/E) ratio below 2.
  • Extremely high short interest — reportedly exceeding 70% of the float — creates conditions for a potential short squeeze if positive catalysts emerge.
  • A steep downtrend dominates the technical picture, with shares trading well below the 50-day and 200-day moving averages, signaling persistent bearish momentum.
  • Weiss Ratings holds a Sell (D-) rating on MLGO, and institutional ownership remains below 2%, reflecting minimal Wall Street conviction.
  • Reaching $8 likely requires a combination of sustained revenue growth, tangible commercialization of quantum algorithm research, and a broader sentiment shift in the micro-cap technology space.

Why the $8 Level Stands Out

MicroAlgo Inc. (MLGO), a Shenzhen-based developer of central processing algorithm solutions, has drawn attention from retail traders due to its sharp price movements and the gap between its fundamentals and current valuation. The stock trades near $4.08 within a 52-week range of $3.02 to $13.60. In this context, the $8 mark represents a notable psychological threshold, positioned roughly midway between the 52-week low and high. It is a level the stock approached during its decline from the peak. Achieving $8 would amount to nearly doubling the current price and could indicate a broader shift in how the market views this micro-cap name.

Company Background

MicroAlgo operates as a subsidiary of WiMi Hologram Cloud Inc. and focuses on custom central processing algorithms used in internet advertising, intelligent chips, and gaming. Revenue comes mainly from mainland China, with some contribution from Hong Kong. With 71 employees and a market capitalization around $45 million, MLGO fits the micro-cap profile, which often brings higher volatility and limited analyst attention. The company completed a 30-for-1 reverse stock split in July 2025 to stay compliant with Nasdaq rules; the move helped stabilize the price temporarily but did not address underlying demand issues. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Factors That Could Support Higher Prices

The case for upside rests on several elements. After earlier losses, MLGO reported net income of $16.3 million in fiscal 2025, a 195% year-over-year gain, and carries a P/E ratio below 2—one of the lowest among technology stocks on major exchanges. The balance sheet appears strong, with cash exceeding $2.3 billion (in CNY terms) against roughly $30.8 million in total debt, supporting a current ratio above 22. The company has also issued more than a dozen press releases in 2026 on quantum-related topics, including image encryption, neural networks, blockchain architecture, and error correction. Any concrete commercialization or partnership in this area could change the narrative around the stock.

Obstacles That Remain

Several factors could limit progress toward $8. Revenue fell 22% year-over-year in fiscal 2025 to about $60 million, with the core China advertising business down more than 31%. Short interest reportedly exceeds 70% of the float, pointing to significant skepticism. Weiss Ratings assigned a Sell (D-) rating in July 2026, and institutional ownership sits near 1.87%. Quantum announcements have been frequent but have not yet produced commercial revenue or disclosed customer deals. The stock’s beta of -0.88 adds another layer of unpredictability, as it can move opposite to broader market trends.

Technical Levels Worth Watching

Technically, the climb to $8 looks difficult. The 200-day moving average is near $5.04 and the 50-day moving average around $4.44, both above the current price and confirming a bearish trend. The $5 area offers the first notable resistance, aligning with the 200-day moving average and prior consolidation between April and June 2026. The $6.50 zone, where the stock peaked in early June 2026, represents the next hurdle. Clearing both would be needed before tackling the psychological barrier of a stock that has fallen roughly 70% from its 52-week high. Support at the $3.02 level, the 52-week low, remains the final line before potential further weakness.

Sentiment and Ownership Picture

Institutional ownership in MLGO stays low at under 2% of shares, while insider ownership is around 47%, largely tied to the parent company’s stake. With limited institutional involvement, price action is driven mainly by retail traders and short sellers, which helps explain the large daily moves. Average trading volume has declined in recent weeks and sits below the three-month average, indicating reduced speculative interest. A sustained move higher would likely need fresh institutional capital or a prominent analyst initiation to gain traction. From what I see, this low institutional presence keeps the stock more sensitive to sentiment shifts.

Final Assessment

The route to $8 for MicroAlgo appears demanding yet feasible under the right conditions. Profitability and a cash-heavy balance sheet offer a foundation many micro-cap peers lack, and elevated short interest creates theoretical room for a squeeze. Still, falling revenue, thin institutional support, ongoing technical weakness, and an unproven quantum pipeline present real headwinds. For the target to become realistic, at least two of the following would need to occur: a turnaround in revenue trends, a meaningful commercial contract or partnership tied to the quantum work, or a sizable short squeeze triggered by an unexpected positive development. Until then, $8 remains more of an aspirational level than a near-term likelihood. Quarterly results, quantum announcements, and short-interest updates stand out as the indicators to follow most closely. I also reviewed recent patterns with Tickeron’s AI Trend Prediction Engine to cross-check the technical setup.

AI Daily Buy/Sell Signals

In my own analysis process, I regularly consult Tickeron’s AI Daily Buy/Sell Signals to supplement chart work and fundamental review. The platform applies artificial intelligence across thousands of stocks and ETFs to produce real-time Buy, Sell, or Hold signals based on technical patterns and market conditions. For a volatile micro-cap like MLGO, these signals can help highlight shifts more quickly than manual review alone.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: MLGO

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


MLGO in +3.17% Uptrend, advancing for three consecutive days on July 31, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MLGO advanced for three days, in of 174 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where MLGO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on MLGO as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MLGO just turned positive on July 17, 2026. Looking at past instances where MLGO's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MLGO entered a downward trend on July 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.135) is normal, around the industry mean (24.022). P/E Ratio (1.925) is within average values for comparable stocks, (72.205). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.917). MLGO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (0.520) is also within normal values, averaging (132.417).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MLGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Twilio (NYSE:TWLO), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.48B. The market cap for tickers in the group ranges from 48.8K to 3.76T. MSFT holds the highest valuation in this group at 3.76T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 3%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 23%. CSAI experienced the highest price growth at 45%, while GYGY experienced the biggest fall at -50%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 73
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
MLGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ComputerCommunications

Profile
Details
Industry
N/A
Address
Taoyuan Street
Phone
+86 75588600589
Employees
71
Web
http://www.microalgor.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.